Nanoparticles and the treatment of hepatocellular carcinoma

Nanoparticles and the treatment of hepatocellular carcinoma

Currently, liver cancer is the leading cause of cancer-related death worldwide, with a low 5-year survival rate, which will further decrease if advanced metastasis is present. Hepatocellular carcinoma (HCC) is the main type. However, due to the lack of specific symptoms in the early stages, it is mo...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Ziyu, Cao Weihua, Li Xinxin, Deng Wen, Jiang Tingting, Wang Shiyu, Yang Liu, Lin Yanjie, Bi Xiaoyue, Lu Yao, Xu Mengjiao, Zhang Lu, Yi Wei, Xie Yao, Li Minghui
Format: Article
Language:English
Published: De Gruyter 2024-12-01
Series:Nanotechnology Reviews
Subjects:
hepatocellular carcinoma
nanoparticles
therapy
tumor microenvironment
drug delivery system
combination with other therapies
Online Access:https://doi.org/10.1515/ntrev-2024-0134
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1515/ntrev-2024-0134

Similar Items